Issue 3/2006
Content (18 Articles)
Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer
Nobuyuki Yamamoto, Yasumasa Nishimura, Kazuhiko Nakagawa, Kaoru Matsui, Masahiro Fukuoka
Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen
Sylvain Poujol, Françoise Bressolle, Jacqueline Duffour, Anissa Gauthey Abderrahim, Cécile Astre, Marc Ychou, Frédéric Pinguet
Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy
Jubo Liu, Helen Lee, Mario Huesca, Aiping Young, Christine Allen
Clindamycin–paclitaxel pharmacokinetic interaction in ovarian cancer patients
Robert Fruscio, Andrea A. Lissoni, Roberta Frapolli, Silvia Corso, Costantino Mangioni, Maurizio D’Incalci, Massimo Zucchetti
Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents
Y.-L. Liu, N. M. Malik, G. J. Sanger, P. L. R. Andrews
Repopulation of osteosarcoma cells after treatment with doxorubicin in the presence of extracellular matrix biopolymers
Revekka Harisi, József Dudás, Gábor Pogány, Ferenc Timár, Júlia Nagy Oláh, Miklós Szendrői, András Jeney
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group
K. Warren, R. Jakacki, B. Widemann, A. Aikin, M. Libucha, R. Packer, G. Vezina, G. Reaman, D. Shaw, M. Krailo, C. Osborne, J. Cehelsky, D. Caldwell, J. Stanwood, S. M. Steinberg, F. M. Balis
Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1)
Seita Matsunaga, Takeshi Asano, Arisa Tsutsuda-Asano, Yoshitaka Fukunaga
The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin
Jan-Erik Damber, Christina Vallbo, Per Albertsson, Bo Lennernäs, Klas Norrby
The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer
Takashi Hirose, Yoshihide Mizutani, Tohru Ohmori, Hiroo Ishida, Takamichi Hosaka, Kohichi Ando, Takao Shirai, Kentaro Okuda, Tsukasa Ohnishi, Naoya Horichi, Hayato Kubota, Mitsuru Adachi
A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial
Masao Ichiki, Masayuki Kawasaki, Koichi Takayama, Kiyoshi Ninomiya, Mutsuo Kuba, Fumiyuki Iwami, Naoki Miyazaki, Kazunori Oishi, Sadanori Takeo, Hisamichi Aizawa, Yoichi Nakanishi
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan
Anshul Gupta, Yang Dai, R. Robert Vethanayagam, Mary F. Hebert, Kenneth E. Thummel, Jashvant D. Unadkat, Douglas D. Ross, Qingcheng Mao
Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells
Timothy C. Cheng, Gerald Manorek, Goli Samimi, Xinjian Lin, Charles C. Berry, Stephen B. Howell
Dihydropyrimidine dehydrogenase deficiency in an Indian population
Muhammad Wasif Saif, Lori Mattison, Tom Carollo, Hany Ezzeldin, Robert B. Diasio
Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy
Nobuo Shinohara, Toru Harabayashi, Shin Suzuki, Kazuhiro Nagao, Haruo Seki, Masashi Murakumo, Kimiyoshi Mitsuhashi, Takayoshi Demura, Satoshi Nagamori, Hideyasu Matsuyama, Katsusuke Naito, Katsuya Nonomura
The cytotoxic and genotoxic potential of 5-aminolevulinic acid on lymphocytes: a comet assay study
E. S. M. Chu, R. W. K. Wu, C. M. N. Yow, T. K. S. Wong, J. Y. Chen
Biliary excretion of etoposide in children with cancer
Gareth J. Veal, Julie Errington, Huw D. Thomas, Alan V. Boddy, Stephen Lowis
Pharmacodynamic properties of methotrexate and AminotrexateTM during weekly therapy
Peter D. Cole, John A. Zebala, María José Alcaraz, Angela K. Smith, John Tan, Barton A. Kamen